InvestorsHub Logo
Followers 4
Posts 1264
Boards Moderated 0
Alias Born 09/06/2017

Re: None

Friday, 02/02/2018 4:56:36 PM

Friday, February 02, 2018 4:56:36 PM

Post# of 3647
Where is this money now???

CardioVascular BioTherapeutics, Inc. Raises $17,250,000 in IPO
March 14, 2005 12:36 PM Eastern Standard Time
HENDERSON, Nev.--(BUSINESS WIRE)--March 14, 2005--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), announced today it has concluded the sale of 1,725,000 shares of its common stock at $10.00 per share, as described in its registration statement filed with the Securities and Exchange Commission.

"CVBT" is the company's ticker symbol. The stock is trading on the Over-the-Counter Bulletin Board (www.otcbb.com).

“This is a great day for our shareholders.”
Tweet this
Daniel C. Montano, CEO of the company, stated, "This is a great day for our shareholders."

The Business: CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) is a biopharmaceutical company focused on developing a new drug for the treatment of cardiovascular diseases where the growth of new blood vessels can improve the outcome for patients with these diseases. It's drug candidate, Cardio Vascu-Grow(TM), is designed to facilitate the growth of new blood vessels in the heart and other tissues with an impaired vascular system.

This news release contains forward-looking statements that involve risks and uncertainties. Actual results and outcomes may differ materially from those discussed or anticipated. For example, statements regarding our future revenues, cash usage and our cash flow breakeven point are forward looking statement. Factors that might affect actual outcomes include, but are not limited to FDA approval of Cardio Vascu-Grow(TM), market acceptance of CardioVascular BioTherapeutics, Inc. products by our customers, future revenues, future expenses, future margins, cash usage, and financial performance. For a more detailed discussion of these and associated risks, see the Company's most recent documents filed with the Securities and Exchange Commission.

Cardio Vascu-Grow(TM) is a trademark of CardioVascular BioTherapeutics, Inc.

Contacts
CardioVascular BioTherapeutics, Inc.
Jody Mack (Media), 702-248-1174
pr@cvbt.com
or
Investor Awareness, Inc
Tony Schor (Investor Relations), 847-971-0922
www.investorawareness.com
CARDIOVASCULAR BIOTHERAPEUTICS, INC.
OTCBB:CVBT View stock quote and chart View SEC Filings

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.